Induction of hepatic Cyp2b and Cyp3a subfamily enzymes by nicardipine and nifedipine in mice

Reference

• AGRAWAL, A. K. and SHAPIRO, B. H., 1996, Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose. Molecular Pharmacology, 49, 523–531.
   PubMedGoogle Scholar
• BERTZ, R. J. and GRANNEMAN, G. R., 1997, Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clinical Pharmacokinetics, 32, 210–258.
   PubMed Web of Science ®Google Scholar
• BOURRIE, M., MEUNIER, V., BERGER, Y. and FABRE, G., 1996, Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalysed by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 277, 321–332.
   PubMed Web of Science ®Google Scholar
• BURKE, M. D., THOMPSON, S., WEAVER, R. J., WOLF, C. R. and MAYER, R. T., 1994, Cytochrome P450 specificities of alkoxyresorufin 0-dealkylation in human and rat liver. Biochemical Pharmacology, 48, 923–936.
   PubMed Web of Science ®Google Scholar
• CAMPANA, C., REGAZZI, M. B., BUGGIA, I. and MOLINARO, M., 1996, Clinically significant drug interactions with cyclosporin. An update. Clinical Pharmacokinetics, 30, 141–179.
   PubMed Web of Science ®Google Scholar
• CHOMCZYNSKI, P. and SACCHI, N., 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156–159.
   PubMed Web of Science ®Google Scholar
• COOPER, K. 0., REIK, L. M., JAYYOSI, Z., BANDIERA, S., KELLY, M., RYAN, D., DANIEL, R., MCCLUSKEY, S. A., LEVIN, W. and THOMAS, P. E., 1993, Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Archives of Biochemistry and Biophysics, 301, 345–354.
   Google Scholar
• DEGAWA, M., TANIMURA, S., AGATSUMA, T. and HASHIMOTO, Y., 1989, Hepatocarcinogenic heterocyclic aromatic amines that induce cytochrome P-448 isozymes, mainly cytochrome P-448H (P-450 1A2), responsible for mutagenic activation of the carcinogens in rat liver. Carcinogenesis, 10, 1119–1122.
   PubMedGoogle Scholar
• DROCOURT, L., PASCUSSI, J.-M., ASSENAT, E., FABRE, J.-M., MAUREL, P. and VILAREM, M.-J., 2001, Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes. Drug Metabolism and Disposition, 29, 1325–1331.
   Google Scholar
• GIBSON, G. G., PLANT, N. J., SWALES, K. E., AYRTON, A. and E1-SANKARY, W., 2002, Receptor-dependent transcriptional activation of cytochrome P4503A gene: induction mechanisms, species differences and interindividual variation in man. Xenobiotica, 32, 165–206.
   Google Scholar
• GUENGERICH, F. P., BRIAN, W. R., IWASAKI, M., SARI, M.-A., BAARNHIELM, C. and BERNTSSON, P., 1991, Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 3A4. Journal of Medicinal Chemistry, 34, 1838–1844.
   Google Scholar
• GUENGERICH, F. P., MARTIN, M. V., BEAUNE, P. H., KREMERS, P., WOLFF, T. and WAXMAN, D. J., 1986, Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry, 261, 5051–5060.
   PubMed Web of Science ®Google Scholar
• JARUKAMJORN, K., SAKUMA, T., MIYATA, J. and NEMOTO, N., 1999, Different regulation of the expression of mouse hepatic cytochrome P450 2B Enzymes by glucocorticoid and phenobarbital. Archives of Biochemistry and Biophysics, 369, 89–99.
   PubMed Web of Science ®Google Scholar
• JARUKAMJORN, K., SAKUMA, T., YAMAMOTO, M., OHARA, A. and NEMOTO, N., 2001, Sex-associated expression of mouse hepatic and renal CYP2B enzymes by glucocorticoid hormones. Biochemical Pharmacology, 62, 161–169.
   PubMed Web of Science ®Google Scholar
• KOCAREK, T. A., SCHUETZ, E., STROM, S. C., FISHER, R. A. and GuzELIAN, P. S., 1995, Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition, 23, 415–421.
   PubMed Web of Science ®Google Scholar
• KONNO, Y. and DEGAWA, M., 2004, Gene activations of CYP2B1 and CYP3A1 by dihydropyridine calcium channel antagonists in the rat liver: the structure—activity relationship. Biological and Pharmaceutical Bulletin, 27, 903–905.
   PubMedGoogle Scholar
• KONNO, Y., NEMOTO, K. and DEGAWA, M., 2003, Induction of hepatic cytochrome P450s responsible for the metabolism of xenobiotics by nicardipine and other calcium channel antagonists in the male rat. Xenobiotica, 33, 119–129.
   PubMed Web of Science ®Google Scholar
• KONNO, Y., SEKIMOTO, M., NEMOTO, K. and DEGAWA, M., 2004, Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine in rats. Toxicology and Applied Pharmacology, 196, 20–28.
   PubMed Web of Science ®Google Scholar
• LANGE, R., BALNY, C. and MAUREL, P., 1984, Inductive and repressive effects of rifampicin on rabbit liver microsomal cytochrome P-450. Biochemical Pharmacology, 33, 2771–2776.
   PubMedGoogle Scholar
• LARSEN, M. C., BRAKE, P. B., PARMAR, D. and JEFCOATE, C. R., 1994, The induction of five rat hepatic P450 cytochromes by phenobarbital and similarly acting compounds is regulated by a sexually dimorphic, dietary-dependent endocrine factor that is highly strain specific. Archives of Biochemistry and Biophysics, 315, 24–34.
   PubMed Web of Science ®Google Scholar
• LECLUYSE, E. L., 2001, Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics. Chemico-Biological Interactions, 134, 283–289.
   PubMed Web of Science ®Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• Lu, C. and LI, A. P., 2001, Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague—Dawley rat, minipig, and beagle dog. Chemico-Biological Interactions, 134, 271–281.
   PubMed Web of Science ®Google Scholar
• MA, B., PRUEKSARITANONT, T. and LIN, J. H., 2000, Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metabolism and Disposition, 28, 125–130.
   PubMed Web of Science ®Google Scholar
• PICHARD, L., FABRE, I., FABRE, G., DOMERGUE, J., SAINT, A. B., MOURAD, G. and MAUREL, P., 1990, Cyclosporin A drug interactions. Screening for inducers and inhibitor of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metabolism and Disposition, 18, 595–606.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL, T. and EZRA, D., 1995, Calcium antagonists: Drug interactions of clinical significance. Drug Safety, 13, 157–187.
   PubMed Web of Science ®Google Scholar
• SAKUMA, T., TAKAI, M., ENDO, Y., KUROIWA, M., OHARA, A., JARUKAMJORN, K., HONMA, R. and NEMOTO, N., 2000, A novel female-specific member of the CYP3A gene subfamily in the mouse liver. Archives of Biochemistry and Biophysics, 377, 153–162.
   PubMed Web of Science ®Google Scholar
• SCHLANZ, K. D., MYRE, S. A. and BOTTORFF, M. B., 1991, Pharmacokinetic interactions with calcium channel antagonists. Clinical Pharmacokinetics, 21, 344–356.
   PubMedGoogle Scholar
• SEREE, E. M., VILLARD, P. H., RE, J. L., MEO, M. D., LACARELLE, B., ATTOLINI, L., DUMENIL, G., CATALIN, J., DURAND, A. and BARRA, Y., 1996, High inducibility of mouse renal CYP2E1 gene by tobacco smoke and its possible effect on DNA single strand breaks. Biochemical Biophysical Research Communications, 219, 429–434.
   PubMed Web of Science ®Google Scholar
• SHAPIRO, B. H., PAMPORI, N. A., LAPENSON, D. P. and WAXMAN, D. J., 1994, Growth hormone-dependent and -independent sexually dimorphic regulation of phenobarbital-induced hepatic cytochromes P450 2B1 and 2B2. Archives of Biochemistry and Biophysics, 312, 234–239.
   PubMed Web of Science ®Google Scholar
• XIE, W., BARWICK, J. L., DOWNES, M., BLUMBERG, B., SIMON, C. M., NELSON, M. C., NEUSCHWANDER-TETRIS, B. A., BRUNT, E. M., GUZELIAN, P. S. and EVANS, R. M., 2000, Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature, 406, 435–439.
   Google Scholar
• YAMADA, H., 00HYAMA, N., HONDA, S., HARA, T., HARADA, N. and OGURI, K., 2002, Estrogen-dependent regulation of the expression of hepatic Cyp2b and 3a isoforms: Assessment using aromatase-deficient mice. Toxicology and Applied Pharmacology, 180, 1–10.
   Google Scholar
• ZANGAR, R. C., OKITA, J. R., KIM, H., THOMAS, P. E., ANDERSON, A., EDWARDS, R. J., SPRINGER, D. L. and OKITA, R. T., 1999, Effect of calcium channel antagonists nifedipine and nicardipine on rat cytochrome P-450 2B and 3A forms. Journal of Pharmacology and Experimental Therapeutics, 290, 1436–1441.
   PubMedGoogle Scholar